Announcement • Feb 05
Glucose Health, Inc. announced that it has received $0.1 million in funding On February 4, 2026, Glucose Health, Inc. closed the transaction. Announcement • Dec 06
Glucose Health, Inc. announced that it has received $0.02 million in funding On December 5, 2025, Glucose Health, Inc. closed the transaction. The transaction included participation from two investors. Announcement • Oct 29
Glucose Health, Inc. Appoints Christopher J. Jemapete to Its Board of Directors, Effective October 29, 2025 Glucose Health, Inc. announced a further strengthening of its Board of Directors with the appointment of Christopher J. Jemapete, effective October 29, 2025. Mr. Jemapete was an early strategic investor in Glucose Health, Inc. beginning in 2017 and continues to maintain a substantial equity position in the company. Mr. Jemapete brings three decades of experience in the financial services and securities industry to the Board of Directors of Glucose Health, Inc., having held senior roles with prominent Wall Street firms, including E.F. Hutton, Shearson Lehman Brothers, and Fidelity Investments. Mr. Jemapete concluded his professional career with a tenure at ALPS Distributors, Inc., located in Denver, Colorado, before his retirement in 2010. Since retiring, Mr. Jemapete has dedicated his efforts to identifying and supporting investment opportunities in the micro-cap sector of the equity markets. Through his deep research methodology, he has developed a comprehensive understanding of the operational and financial challenges faced by emerging companies—particularly in areas related to capital formation, financing structures, and the execution of strategic growth initiatives. As one of the earliest strategic investors in Glucose Health, Inc. Mr. Jemapete has participated in each of the Private Placements offered by Glucose Health, Inc. since 2019 and played an essential role in the successful raising of over $2 million in capital. His firm conviction in the mission of Glucose Health, Inc. —to deliver functional food and beverage products designed to address the growing public health challenges of obesity and diabetes—led to his decision today, to join the Company’s Board of Directors. Mr. Jemapete holds a Bachelor of Science degree in Marketing from Fairfield University in Fairfield, Connecticut, and completed a two-year graduate program at Adelphi University in Garden City, New York, earning certification as a Certified Financial Planner. 
